ÀÎÇÏ´ëÇб³/¿Í½ÌÅÏ´ëÇб³ °øµ¿Çмú½ÉÆ÷Áö¿ò °³ÃÖ
- ÀÛ¼ºÀÚ
- °ü¸®ÀÚ
- ÀÛ¼ºÀÏ
- 2007-10-05
- Á¶È¸
- 5901
ÀÎÇÏ´ëÇб³/¿Í½ÌÅÏ´ëÇб³ °øµ¿Çмú½ÉÆ÷Áö¿òÀÌ ¾Æ·¡¿Í °°ÀÌ °³ÃֵǿÀ´Ï ȸ¿ø ¿©·¯ºÐµéÀÇ ¸¹Àº °ü½É°ú Âü¿© ºÎŹµå¸³´Ï´Ù.
= ¾Æ·¡ =
³»¿ë : Inha Univertsity/University of Washington Joint Symposium
ÀϽà : 2007³â 10¿ù 25ÀÏ(¸ñ) ¿ÀÈÄ 1½Ã ~ 3½Ã 30ºÐ
Àå¼Ò : ÀÎÇÏ´ëÇб³ ¸ÞÀÎ Ä·ÆÛ½º Á¤¼®Çмú°ü 8Ãþ
ÆòÁ¡ : Ç÷¾×Á¾¾çºÐ°ú 2ÆòÁ¡
*Âü°¡ºñ, ÁÖÂ÷·á ¹× ÇÐȸ ÈÄ Ä¬Å×ÀÏ ÆÄƼ ¹«·á
¿¬ÀÚ¹× ¿¬Á¦
ÁÂÀå : ±èö¼ö(ÀÎÇÏ´ëÇб³)
13:00-13:50 Immunotherapy against HER-2/neu in the treatment of breast cancer (Mary L Nora Disis MD, University of Washington )
13:50-14:40 Molecular signatures of gratft versus host disease;The utility of whole genome approach (Seonyang Park MD PhD, Seoul National University )
14:40-15:30 Hematopoietic stem cell transplantantion using reduced intensity conditioning for elderly patients with hematologic malignancy (Rainer F Storb MD, University of Washington )
= ¾Æ·¡ =
³»¿ë : Inha Univertsity/University of Washington Joint Symposium
ÀϽà : 2007³â 10¿ù 25ÀÏ(¸ñ) ¿ÀÈÄ 1½Ã ~ 3½Ã 30ºÐ
Àå¼Ò : ÀÎÇÏ´ëÇб³ ¸ÞÀÎ Ä·ÆÛ½º Á¤¼®Çмú°ü 8Ãþ
ÆòÁ¡ : Ç÷¾×Á¾¾çºÐ°ú 2ÆòÁ¡
*Âü°¡ºñ, ÁÖÂ÷·á ¹× ÇÐȸ ÈÄ Ä¬Å×ÀÏ ÆÄƼ ¹«·á
¿¬ÀÚ¹× ¿¬Á¦
ÁÂÀå : ±èö¼ö(ÀÎÇÏ´ëÇб³)
13:00-13:50 Immunotherapy against HER-2/neu in the treatment of breast cancer (Mary L Nora Disis MD, University of Washington )
13:50-14:40 Molecular signatures of gratft versus host disease;The utility of whole genome approach (Seonyang Park MD PhD, Seoul National University )
14:40-15:30 Hematopoietic stem cell transplantantion using reduced intensity conditioning for elderly patients with hematologic malignancy (Rainer F Storb MD, University of Washington )